A highly significant implication of our discovery of the USP10-SKP2-Bcr-Abl pathway is its provision of a new strategy to overcome the resistance to TKIs caused by T315I mutation.
← all excerpts
USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia.
1
—
—